MedTrace Logo

The Effects of Synbiotics on Morbidity and Mortality in Preterm Infants

NCT01807858 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2013-03-08

No results posted yet for this study

Summary

Study, the inclusion of very low birth weight premature infants followed in Dr.Sami Ulus Maternity and Children Training and Research Hospital, Department of Neonatology; be randomized to very low birth weight premature infants began eating until you are discharged from the hospital once a day to feed a group+ 900 mg of 5 billion active Bifidobacterium lactis, the addition of chicory inulin, in the other group given placebo; Patients taking weekly blood cultures, the presence of residues in both groups during feeding, to evaluate the incidence of NEC and sepsis are planned. Randomization and the number of patients planned to separate into groups.

Conditions

  • Necrotizing Enterocolitis
  • Sepsis

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium lactis

5 billion active Bifidobacterium lactis

DIETARY_SUPPLEMENT

Bifidobacterium lactis plus İnülin

5 billion Bifidobacterium lactis plus 900 mg İnülin per day will be given

OTHER

Maltodextrin

Maltodextrin

DIETARY_SUPPLEMENT

İnulin

900 mg inulin per day will be given

Sponsors & Collaborators

  • Dr. Sami Ulus Children's Hospital

    lead OTHER

Principal Investigators

  • Dilek Dilli, MD · Assoc Prof

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Max Age
30 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-10-31
Completion
2013-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01807858 on ClinicalTrials.gov